| Literature DB >> 34166622 |
Frédéric Mourcin1, Léa Verdière1, David Roulois1, Rada Amin1, Claire Lamaison1, Vonick Sibut1, Brice Thamphya1, Céline Pangault2, Céline Monvoisin1, Sarah Huet3, Marine Seffals4, Sylvain Baulande5, Fatima Mechta-Grigoriou6, Patricia Legoix5, Delphine Rossille2, Marion Guirriec1, Simon Léonard1, Guillaume Cartron7, Gilles Salles8, Thierry Fest2, Karin Tarte9.
Abstract
Lymphoid stromal cells (LSCs) are essential organizers of immune responses. We analyzed tonsillar tissue by combining flow cytometry, in situ imaging, RNA sequencing, and functional assays, defining three distinct human LSC subsets. The integrin CD49a designated perivascular stromal cells exhibiting features of local committed LSC precursors and segregated cytokine and chemokine-producing fibroblastic reticular cells (FRCs) supporting B and T cell survival. The follicular dendritic cell transcriptional profile reflected active responses to B cell and non-B cell stimuli. We therefore examined the effect of B cell stimuli on LSCs in follicular lymphoma (FL). FL B cells interacted primarily with CD49a+ FRCs. Transcriptional analyses revealed LSC reprogramming in situ downstream of the cytokines tumor necrosis factor (TNF) and transforming growth factor β (TGF-β), including increased expression of the chemokines CCL19 and CCL21. Our findings define human LSC populations in healthy tissue and reveal bidirectional crosstalk between LSCs and malignant B cells that may present a targetable axis in lymphoma.Entities:
Keywords: B cell lymphoma; cancer-associated fibroblasts; chemokines; fibroblastic reticular cells; follicular dendritic cells; tumor microenvironment
Year: 2021 PMID: 34166622 DOI: 10.1016/j.immuni.2021.05.019
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745